PDL BioPharma Overview

  • Service
  • Lender

  • Year Founded
  • 1986

Year Founded

  • Professionals
  • 326

Professionals

  • Financed Companies
  • 7

  • Financings
  • 8

  • Serviced Investors
  • 1

PDL BioPharma General Information

Description

Founded in 1986, PDL BioPharma is a lender headquartered in Reno, Nevada. The firm offers services in intellectual property asset management, investing in new royalty bearing assets, providing debt facilities, growth capital, financing solutions and financial monetization of royalty streams. PDL BioPharma caters to industries including biotechnology, healthcare and pharmaceuticals.

Contact Information

Website
www.pdl.com
Formerly Known As
Protein Design Labs, Inc.
Year Founded
1986
Service Provider Type
Lender

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PDL BioPharma Investment Preferences

Preferred Industries Preferred Verticals Preferred Deal Types Geographic Preferences Transaction Amount

This information is available in the PitchBook Platform. To explore PDL BioPharma‘s full profile, request access.

Request a free trial

PDL BioPharma FAQs

  • When was PDL BioPharma founded?

    PDL BioPharma was founded in 1986.

  • What is the size of PDL BioPharma?

    PDL BioPharma total number of employees/professionals is 326.

  • What service provider type is PDL BioPharma?

    PDL BioPharma's service provider type is Lender.

  • What companies has PDL BioPharma invested in or acquired?

    PDL BioPharma has invested in or acquired companies like Evofem Biosciences, Noden Pharma, and Axogen.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process